Newly examined EFTA documents reveal Jeffrey Epstein framing CRISPR as a “taboo” science he helped curate; credited with catalyzing a collaboration between Martin Nowak and George Church on gene drive research; engaged as a prospective investor in early CRISPR commercialization ventures; and holding equity in a longevity genomics startup run by Church’s network — all documented between 2014 and 2017 before the gene-editing technology completed its shift from laboratory breakthrough to commercial infrastructure.
This article is part of my Epstein Files series, the reporting I published as I worked through the federal record in real time. That reporting became the foundation of Shadow Empire: The Epstein Files.
The articles followed individual threads as I found them. The book follows how they connect: thirty-four chapters, in the order events happened, with every claim footnoted to a document at justice.gov/epstein and its federal Bates number. Where an article and the book differ, the book reflects the fuller record.
The rest of this article continues below for paid subscribers. For the complete account, the book is the place to start.




